FRT

(redirected from FLT1)
Also found in: Dictionary, Medical, Encyclopedia.
References in periodicals archive ?
Eight genes (EGER, MET, FLT1, PGR, PLAU, KIT, MKI67, and TWIST1) were significantly differentially expressed between those 2 groups (see Table 12 in the online Data Supplement).
Thomas, "N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domain," PloS One, vol.
HPXN, NID2, and FLT1 were the glycogenes with the highest degree in BvL579, BvM501, and LvM442 networks, respectively.
These families include VEGF receptor (VEGFR) types 1 (FLT1), 2 (KDR), and 3 (FLT4); platelet-derived growth factor receptors A and B (PDGFRA and PDGFRB); the stem cell factor receptor (cKIT); FMS-like tyrosine kinase 3 (FLT3); colony-stimulating factor 1 receptor (CSF-1R); and glial cell line-derived neurotrophic factor receptor [rearranged during transfection (RET)].
On this task, the research team was able to identify two markers, the receptors Flt1 (VEGFR1) and Flt4 (VEGFR3), on the surface of CPCs with which these cells can be clearly identified while fully preserving their biological function.
In the first example, we screened subjects for SNPs in p53 response elements of p53 downstream genes (FLT1, TLR8y RRM1, MDM2).
Researchers determined that the new pathway works by myeloid cells utilizing the Wnt pathway could regulate expression of a gene known as Flt1. Flt1 encodes a protein, which suppresses vascular growth by binding vascular endothelial growth factor (VEGF)
Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin D1, pRb, p53 and p27 protein expression.
In addition, hypoxia tended to increase VEGF receptor Flt1 (P<0.06, 139 [+ or -] 9%), and tended to decrease VEGF receptor KDR (P=0.07; 82 [+ or -] 4%) and endothelial nitric oxide receptor (NOS3; P<0.1, 87 [+ or -] 7%) mRNA expression in COT explants.
Furthermore, TAMs express VEGFR1 (flt1) [18] and respond to its activation by migrating and modulating their biological activity in response to VEGFR1 ligands [19] such as VEGF produced by tumour cells.